Provided by Tiger Trade Technology Pte. Ltd.

TherapeuticsMD

2.07
+0.01000.49%
Post-market: 2.070.0005+0.02%16:59 EDT
Volume:16.23K
Turnover:33.68K
Market Cap:23.96M
PE:-110.41
High:2.09
Open:2.06
Low:2.06
Close:2.06
52wk High:2.95
52wk Low:0.9900
Shares:11.57M
Float Shares:9.49M
Volume Ratio:0.59
T/O Rate:0.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0187
EPS(LYR):-0.0527
ROE:-1.08%
ROA:-2.88%
PB:0.88
PE(LYR):-39.25

Loading ...

TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
May 09

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 06

TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
May 05

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 02

TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
May 01

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 29

TherapeuticsMD Inc. Stock Sheds 5.5%, Underperforms Market

Dow Jones
·
Apr 28

TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Apr 23

TherapeuticsMD Inc. Stock Rises 5.8%, Outperforms Market

Dow Jones
·
Apr 21

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 15

TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 08

TherapeuticsMD Inc. Stock Rallies 10.0%, Outperforms Market

Dow Jones
·
Apr 07

TherapeuticsMD Explains Brief Delay In Annual Filing

TIPRANKS
·
Apr 01

TherapeuticsMD delays 2025 10-K after filing omits auditor report

Reuters
·
Apr 01

TherapeuticsMD Inc. Stock Rises Tuesday, Still Underperforms Market

Dow Jones
·
Apr 01

TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy

TIPRANKS
·
Mar 31

TherapeuticsMD Q4 EPS $(0.06) Down From $0.01 YoY, Sales $893.000K Up From $667.000K YoY

Benzinga Earnings
·
Mar 31

TherapeuticsMD Inc. Stock Slides 5.2%, Underperforms Market

Dow Jones
·
Mar 31

TherapeuticsMD reports FY25 EPS (6c) vs. (20c) last year

TIPRANKS
·
Mar 31

TherapeuticsMD FY25 net loss from continuing operations narrows 73.91% to $0.7 million

Reuters
·
Mar 31